Solutions
Sequencing and Genomics
See productsWe want to democratise genetics by playing an active and facilitating role in the implementation of advanced diagnostic methodologies.
At the same time, we would like to contribute to scientific research, a better understanding of disease mechanisms and the development of new therapies.
We represent Illumina, the world leader in next-generation sequencing (NGS), and offer not only a wide range of sequencers but also solutions for all stages of human life, from prenatal to postnatal, including the diagnosis of genetic, oncological and infectious diseases.
Also in the field of oncology, we have teamed up with Pillar Biosciences, providing healthcare providers and research centres with access to the most accurate NGS panels in personalised medicine.
With Bionano, which promises to revolutionise cytogenomics with optical genomic mapping technology, we are facilitating the diagnosis of haemato-oncological diseases and complex genetic disorders, but also the quality control of cell cultures.
Our partners



Products for Sequencing and Genomics

NovaSeq X Plus answers the most complex biological questions, facilitating large projects with large numbers of samples and deep sequencing. With innovations in chemistry, optics and software, it offers fast and sustainable access to high-quality genetic information, identifying rare events.
NovaSeq X Plus Sequencing System*
20084804
NextSeq 2000 maximises laboratory developments with high sequencing power and throughput for applications such as single cell gene expression, whole genome/exome sequencing and metagenomics. Integrated with the DRAGEN server, it is compatible with advanced XLEAP-SBS chemistry.
NextSeq 2000 Sequencing System*
20038897
The MiSeq i100 Plus is the simplest and fastest benchtop sequencer, with reagents that are stored at room temperature and no need for maintenance after each run. Integrated with the DRAGEN server, it offers same-day results for applications such as microbial genomics, microbiology, infectious diseases and oncology.
Miseq i100 Plus Sequencing System*
20115695
The Nextseq 550Dx allows sequencing in accordance with the CE-IVD regulations, which are crucial, for example, in non-invasive prenatal diagnosis, but also in research mode (RUO). This sequencer enables a wide range of applications from NGS sequencing to arrays.
NextSeq™ 550Dx Sequencing System*
20005715
A simple and scalable non-invasive prenatal in vitro diagnostic solution that can analyse 24, 48 or 96 samples per test, offering a comprehensive view of foetal chromosomes with a wide menu of tests and validated in a clinical accuracy study of >2300 samples, with sensitivity and specificity >99.9% for trisomies 21, 18 and 13.
VeriSeq NIPT Sample Prep Kit (48 samples)*
15066801
This NGS library preparation kit features an integrated, fast and high-performance workflow for whole-genome sequencing applications. The flexible protocol accommodates a wide range of sample types for different sequencing applications and is compatible with automation.
WGS Illumina® DNA PCR-Free Prep, Tagmentation (96 Samples)*
20041795
This kit features a quick and easy-to-use workflow for preparing NGS libraries, with an updated probe panel for the human whole exome that enables cost-effective and reliable sequencing.
Illumina DNA Prep with Exome 2.5 Enrichment, (S) Tagmentation (96Samples, 12-plex)*
20077595
This kit allows DNA sequencing of 523 genes and RNA sequencing of 55 genes, enabling MSI and TMB analysis. The optional content of the TruSight Oncology 500 HRD kit includes coverage of ~25K SNPs to assess homologous recombination deficiency using a comprehensive genomic instability score (LOH+TAI+LST).
TruSight Oncology 500 DNA/RNA Kit for Use with NextSeq plus Velsera interpretation report (16 indexes, 24 Samples)*
20032627
This kit combines the oncoReveal™ Multi-Cancer v4 panel with CNV, a robust NGS panel that targets multiple genetic regions and enables users to explore DNA from solid tumour samples, with the oncoReveal™ Multi-Cancer RNA Fusion v2 panel, which targets fusion events using cDNA from FFPE or frozen tissue or cell lines.
oncoRevealTM Multi-Cancer with CNV and RNA Fusion Panel (48 reactions)*
HNA-HS-1001-48
This robust NGS library preparation kit targets 58 genes relevant to the study of myeloid tumours, including the complete coding region of 18 genes.
oncoRevealTM Myeloid Panel (24 reactions)*
HDA-MY-1001-24
Stratys can detect all classes of structural variants with innovative optical genomic mapping (OGM) technology. This powerful instrument has a capacity of 12 single-sample, random-access chips, allowing cytogenomic analysis of up to 260 samples per week.
Stratys System with Access Server*
90176What sets our solutions apart

Leadership in innovation

Data protection

Robustness

Precision

Ease and simplicity
Related services
Training and scientific support
Promotion and distribution
Technical assistance
* The VeriSeq NIPT Sample Prep Kit and NextSeq 550Dx Sequencing System are medical devices for in vitro diagnostic use, exclusively for professional use. Please carefully read the information contained in the labeling and user manual for details, warnings, and precautions related to the use of these devices. The oncoReveal, Stratys, TruSight Oncology 500 DNA/RNA Kit, Illumina DNA Prep with Exome 2.5 Enrichment, (S) Tagmentation, WGS Illumina DNA PCR-FREE Prep Tagmentation, NextSeq 2000 Sequencing System, NovaSeq X Plus Sequencing System, and MiSeq i100 Plus Sequencing System are intended for research purposes.
The content, as well as all information provided on this website is for informational use only and is not intended to be a substitute for professional medical advice, diagnosis or treatment in any way. Always talk to your doctor about diagnosis and treatment information and make sure you understand and follow this information carefully. Product images are for illustrative purposes only.